Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thalidomide | 4 | 2024 | 885 | 1.720 |
Why?
|
Multiple Myeloma | 20 | 2024 | 5146 | 1.430 |
Why?
|
Neoplasms, Second Primary | 3 | 2022 | 1052 | 0.970 |
Why?
|
Ubiquitin-Protein Ligases | 6 | 2024 | 1899 | 0.850 |
Why?
|
Myelodysplastic Syndromes | 3 | 2022 | 1394 | 0.700 |
Why?
|
Leukemia, Myeloid, Acute | 6 | 2024 | 3615 | 0.650 |
Why?
|
Hematologic Neoplasms | 4 | 2024 | 1896 | 0.540 |
Why?
|
Hematopoiesis | 7 | 2023 | 2050 | 0.440 |
Why?
|
B-Cell Maturation Antigen | 3 | 2023 | 149 | 0.420 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2022 | 1073 | 0.420 |
Why?
|
Saccharomyces cerevisiae | 4 | 2011 | 2688 | 0.420 |
Why?
|
Immunotherapy, Adoptive | 5 | 2024 | 1469 | 0.370 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2011 | 106 | 0.370 |
Why?
|
DNA, Fungal | 2 | 2011 | 275 | 0.370 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2011 | 122 | 0.360 |
Why?
|
Precancerous Conditions | 1 | 2017 | 980 | 0.350 |
Why?
|
Heterochromatin | 2 | 2011 | 293 | 0.350 |
Why?
|
Saccharomyces cerevisiae Proteins | 4 | 2011 | 1841 | 0.330 |
Why?
|
RNA Polymerase II | 2 | 2011 | 539 | 0.320 |
Why?
|
Mutation | 17 | 2024 | 30053 | 0.310 |
Why?
|
Phthalimides | 2 | 2024 | 34 | 0.290 |
Why?
|
Piperidones | 2 | 2024 | 37 | 0.290 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 2 | 2020 | 269 | 0.270 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2022 | 5672 | 0.270 |
Why?
|
Plasma Cells | 2 | 2022 | 599 | 0.270 |
Why?
|
Immunotherapy | 2 | 2021 | 4652 | 0.260 |
Why?
|
Histones | 4 | 2011 | 2580 | 0.250 |
Why?
|
Transplantation, Autologous | 4 | 2023 | 2115 | 0.250 |
Why?
|
Tumor Suppressor Protein p53 | 4 | 2023 | 2917 | 0.240 |
Why?
|
Morpholines | 2 | 2024 | 581 | 0.230 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 232 | 0.210 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 6 | 1 | 2021 | 27 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 220 | 0.200 |
Why?
|
Casein Kinase Ialpha | 1 | 2021 | 26 | 0.200 |
Why?
|
Endothelium, Corneal | 1 | 2024 | 215 | 0.200 |
Why?
|
Agammaglobulinemia | 1 | 2023 | 171 | 0.200 |
Why?
|
Chromatin | 6 | 2023 | 2961 | 0.200 |
Why?
|
DNA, Intergenic | 1 | 2022 | 105 | 0.190 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2024 | 305 | 0.190 |
Why?
|
Antibodies, Bispecific | 1 | 2023 | 196 | 0.180 |
Why?
|
Fasciitis | 1 | 2021 | 67 | 0.180 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2021 | 214 | 0.180 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2021 | 176 | 0.180 |
Why?
|
Splenic Neoplasms | 1 | 2021 | 94 | 0.180 |
Why?
|
T-Lymphocytes | 3 | 2023 | 10194 | 0.180 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 191 | 0.170 |
Why?
|
Genes, p53 | 1 | 2022 | 712 | 0.170 |
Why?
|
Polymerization | 1 | 2020 | 158 | 0.170 |
Why?
|
Neoplasms | 4 | 2024 | 22173 | 0.170 |
Why?
|
Lymphoma, B-Cell, Marginal Zone | 1 | 2021 | 178 | 0.160 |
Why?
|
Genome, Fungal | 2 | 2011 | 203 | 0.160 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 624 | 0.160 |
Why?
|
Humans | 53 | 2024 | 761596 | 0.160 |
Why?
|
Paraproteinemias | 1 | 2021 | 248 | 0.160 |
Why?
|
Nucleosomes | 3 | 2011 | 488 | 0.160 |
Why?
|
Plasmacytoma | 1 | 2019 | 171 | 0.150 |
Why?
|
Heavy Chain Disease | 1 | 2018 | 19 | 0.150 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2018 | 62 | 0.150 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2024 | 2898 | 0.150 |
Why?
|
Cyclins | 1 | 2020 | 594 | 0.150 |
Why?
|
Polyadenylation | 1 | 2018 | 117 | 0.140 |
Why?
|
Immunoglobulin M | 1 | 2022 | 1526 | 0.140 |
Why?
|
Eosinophilia | 1 | 2021 | 560 | 0.140 |
Why?
|
DNA Damage | 2 | 2023 | 2449 | 0.140 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 11742 | 0.140 |
Why?
|
Purines | 1 | 2020 | 607 | 0.140 |
Why?
|
Respiratory Tract Infections | 1 | 2023 | 1010 | 0.130 |
Why?
|
Skull Base Neoplasms | 1 | 2019 | 270 | 0.130 |
Why?
|
Introns | 1 | 2018 | 981 | 0.120 |
Why?
|
Substrate Specificity | 1 | 2019 | 1791 | 0.120 |
Why?
|
Melphalan | 3 | 2023 | 420 | 0.120 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2024 | 1551 | 0.120 |
Why?
|
Alleles | 4 | 2021 | 6864 | 0.120 |
Why?
|
Lysine | 2 | 2009 | 993 | 0.120 |
Why?
|
Chromatin Immunoprecipitation | 3 | 2011 | 855 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1374 | 0.110 |
Why?
|
Telomere | 2 | 2011 | 943 | 0.110 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2016 | 647 | 0.110 |
Why?
|
Molecular Targeted Therapy | 2 | 2024 | 2811 | 0.110 |
Why?
|
Clone Cells | 1 | 2016 | 1659 | 0.110 |
Why?
|
Silent Information Regulator Proteins, Saccharomyces cerevisiae | 2 | 2011 | 63 | 0.110 |
Why?
|
Acetylation | 3 | 2009 | 1055 | 0.100 |
Why?
|
Proton-Phosphate Symporters | 1 | 2011 | 9 | 0.100 |
Why?
|
Adenosine Triphosphatases | 2 | 2023 | 836 | 0.100 |
Why?
|
Leukocytes | 1 | 2020 | 2026 | 0.100 |
Why?
|
Lymphoma | 1 | 2021 | 1901 | 0.100 |
Why?
|
Transcription Factors | 4 | 2024 | 12130 | 0.100 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8002 | 0.090 |
Why?
|
Protein Binding | 3 | 2020 | 9353 | 0.090 |
Why?
|
HMGN Proteins | 1 | 2010 | 7 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1393 | 0.090 |
Why?
|
Transcription, Genetic | 3 | 2011 | 7593 | 0.090 |
Why?
|
DNA Copy Number Variations | 2 | 2016 | 2020 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 1 | 2022 | 3397 | 0.090 |
Why?
|
High Mobility Group Proteins | 1 | 2010 | 177 | 0.090 |
Why?
|
Genes, Mating Type, Fungal | 1 | 2009 | 25 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2022 | 3617 | 0.080 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 1640 | 0.080 |
Why?
|
Mice | 8 | 2024 | 81539 | 0.080 |
Why?
|
Mitoxantrone | 2 | 2019 | 148 | 0.080 |
Why?
|
Drosophila Proteins | 3 | 2008 | 1699 | 0.080 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4758 | 0.080 |
Why?
|
Pyridines | 1 | 2020 | 2875 | 0.080 |
Why?
|
Dioxygenases | 2 | 2020 | 345 | 0.080 |
Why?
|
Animals | 13 | 2024 | 168475 | 0.070 |
Why?
|
Apoptosis | 2 | 2023 | 9490 | 0.070 |
Why?
|
Cell Cycle Proteins | 3 | 2022 | 3449 | 0.070 |
Why?
|
Etoposide | 2 | 2019 | 634 | 0.070 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3204 | 0.070 |
Why?
|
Cytarabine | 2 | 2019 | 698 | 0.070 |
Why?
|
Mitochondria | 1 | 2019 | 3624 | 0.070 |
Why?
|
Gene Silencing | 2 | 2011 | 1509 | 0.070 |
Why?
|
Drosophila | 2 | 2005 | 1495 | 0.070 |
Why?
|
Antineoplastic Agents | 3 | 2024 | 13642 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2021 | 5305 | 0.060 |
Why?
|
Ubiquitination | 2 | 2020 | 1007 | 0.060 |
Why?
|
Ligands | 2 | 2023 | 3272 | 0.060 |
Why?
|
Sequence Deletion | 1 | 2009 | 1494 | 0.060 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 1739 | 0.060 |
Why?
|
Repressor Proteins | 2 | 2022 | 2986 | 0.060 |
Why?
|
Trans-Activators | 2 | 2005 | 2856 | 0.060 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 82 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 2 | 2020 | 1321 | 0.060 |
Why?
|
Cell Line, Tumor | 4 | 2023 | 16990 | 0.060 |
Why?
|
Histone Deacetylases | 1 | 2008 | 720 | 0.060 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2022 | 8554 | 0.050 |
Why?
|
Dexamethasone | 2 | 2023 | 1948 | 0.050 |
Why?
|
Fuchs' Endothelial Dystrophy | 1 | 2024 | 103 | 0.050 |
Why?
|
Allosteric Site | 1 | 2022 | 103 | 0.050 |
Why?
|
Proto-Oncogene Proteins | 3 | 2020 | 4514 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 366 | 0.050 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2023 | 412 | 0.050 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1263 | 0.050 |
Why?
|
DNA-Binding Proteins | 4 | 2020 | 9610 | 0.050 |
Why?
|
Adult | 11 | 2024 | 221210 | 0.050 |
Why?
|
Transcriptional Elongation Factors | 1 | 2022 | 165 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2005 | 744 | 0.040 |
Why?
|
Prevalence | 1 | 2017 | 15733 | 0.040 |
Why?
|
Dipeptides | 1 | 2022 | 391 | 0.040 |
Why?
|
Models, Molecular | 2 | 2020 | 5439 | 0.040 |
Why?
|
Gene Regulatory Networks | 1 | 2009 | 1745 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2022 | 17904 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2011 | 5790 | 0.040 |
Why?
|
Inheritance Patterns | 1 | 2022 | 341 | 0.040 |
Why?
|
Solvents | 1 | 2020 | 295 | 0.040 |
Why?
|
Toll-Like Receptor 9 | 1 | 2020 | 233 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2021 | 740 | 0.040 |
Why?
|
Drosophila melanogaster | 1 | 2008 | 1712 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2021 | 212 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3801 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2023 | 858 | 0.040 |
Why?
|
Synthetic Biology | 1 | 2020 | 185 | 0.040 |
Why?
|
Binding Sites | 2 | 2021 | 6056 | 0.040 |
Why?
|
Aged | 8 | 2024 | 169310 | 0.040 |
Why?
|
Serine | 1 | 2022 | 831 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2024 | 1136 | 0.040 |
Why?
|
Aminopyridines | 1 | 2022 | 573 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2022 | 569 | 0.040 |
Why?
|
Middle Aged | 9 | 2024 | 220921 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 2 | 2018 | 2048 | 0.040 |
Why?
|
Female | 12 | 2024 | 392705 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2020 | 1749 | 0.040 |
Why?
|
Quality of Life | 3 | 2024 | 13367 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2022 | 3076 | 0.030 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2020 | 655 | 0.030 |
Why?
|
Cryoelectron Microscopy | 1 | 2020 | 650 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 26129 | 0.030 |
Why?
|
Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 2016 | 91 | 0.030 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2022 | 727 | 0.030 |
Why?
|
Germ Cells | 1 | 2020 | 634 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2018 | 519 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2023 | 21019 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2019 | 20568 | 0.030 |
Why?
|
Cell Cycle | 1 | 2023 | 2932 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1059 | 0.030 |
Why?
|
Biological Products | 1 | 2024 | 914 | 0.030 |
Why?
|
Stem Cell Transplantation | 1 | 2023 | 1600 | 0.030 |
Why?
|
Maximum Tolerated Dose | 1 | 2017 | 883 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2023 | 9280 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2020 | 733 | 0.030 |
Why?
|
Male | 9 | 2024 | 360846 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1552 | 0.030 |
Why?
|
Protein Conformation | 1 | 2022 | 3968 | 0.030 |
Why?
|
Lymphotoxin-beta | 1 | 2014 | 14 | 0.030 |
Why?
|
DNA Repair | 1 | 2023 | 2046 | 0.030 |
Why?
|
Loss of Heterozygosity | 1 | 2016 | 662 | 0.030 |
Why?
|
Kinetics | 1 | 2021 | 6374 | 0.030 |
Why?
|
Early Growth Response Protein 1 | 1 | 2014 | 133 | 0.030 |
Why?
|
Age of Onset | 1 | 2020 | 3306 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2022 | 2116 | 0.030 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 184 | 0.030 |
Why?
|
Chromosomes | 2 | 2008 | 578 | 0.030 |
Why?
|
Remission Induction | 1 | 2017 | 2397 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 23996 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2547 | 0.020 |
Why?
|
Leiomyoma | 1 | 2016 | 636 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36426 | 0.020 |
Why?
|
Prognosis | 2 | 2022 | 29629 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2022 | 4243 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2017 | 1263 | 0.020 |
Why?
|
Nuclear Proteins | 2 | 2020 | 5799 | 0.020 |
Why?
|
Proteome | 1 | 2021 | 1862 | 0.020 |
Why?
|
Base Sequence | 1 | 2022 | 12441 | 0.020 |
Why?
|
Bone Marrow | 1 | 2021 | 2911 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2016 | 2220 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 517 | 0.020 |
Why?
|
Caregivers | 1 | 2022 | 2238 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2014 | 732 | 0.020 |
Why?
|
Telomere-Binding Proteins | 1 | 2011 | 119 | 0.020 |
Why?
|
S Phase | 1 | 2011 | 421 | 0.020 |
Why?
|
Odds Ratio | 1 | 2022 | 9647 | 0.020 |
Why?
|
Gene Frequency | 1 | 2016 | 3606 | 0.020 |
Why?
|
Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2008 | 20 | 0.020 |
Why?
|
ras Proteins | 1 | 2014 | 1054 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6180 | 0.020 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2009 | 223 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9319 | 0.020 |
Why?
|
Tumor Microenvironment | 1 | 2021 | 3878 | 0.020 |
Why?
|
Histone Deacetylase 1 | 1 | 2008 | 133 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2014 | 1410 | 0.020 |
Why?
|
SOXB1 Transcription Factors | 1 | 2009 | 286 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2014 | 2021 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2022 | 4481 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 12463 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2024 | 22174 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2021 | 10451 | 0.020 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 1745 | 0.020 |
Why?
|
Young Adult | 2 | 2024 | 59260 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7581 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2014 | 1886 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2020 | 58984 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2024 | 18255 | 0.020 |
Why?
|
Smoking | 1 | 2022 | 9053 | 0.020 |
Why?
|
Survival Analysis | 1 | 2017 | 10090 | 0.020 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2005 | 427 | 0.010 |
Why?
|
RNA | 1 | 2014 | 2725 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 2005 | 555 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2014 | 2571 | 0.010 |
Why?
|
Hemorrhage | 1 | 2016 | 3424 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3639 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2014 | 2057 | 0.010 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2008 | 634 | 0.010 |
Why?
|
Cell Division | 1 | 2011 | 4465 | 0.010 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2005 | 945 | 0.010 |
Why?
|
Eye Abnormalities | 1 | 2005 | 242 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4740 | 0.010 |
Why?
|
Depression | 1 | 2022 | 8126 | 0.010 |
Why?
|
Signal Transduction | 1 | 2005 | 23447 | 0.010 |
Why?
|
Transgenes | 1 | 2005 | 1010 | 0.010 |
Why?
|
X Chromosome | 1 | 2005 | 816 | 0.010 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 4415 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2009 | 1974 | 0.010 |
Why?
|
DNA | 1 | 2014 | 7213 | 0.010 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2011 | 2872 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2018 | 22176 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2009 | 2418 | 0.010 |
Why?
|
Protein Subunits | 1 | 2002 | 943 | 0.010 |
Why?
|
Prospective Studies | 1 | 2023 | 54423 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2016 | 20100 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 64685 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4615 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2014 | 7859 | 0.010 |
Why?
|
Genome, Human | 1 | 2009 | 4425 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88326 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2024 | 80647 | 0.010 |
Why?
|
Risk Factors | 1 | 2022 | 74213 | 0.010 |
Why?
|
Proteomics | 1 | 2008 | 3848 | 0.010 |
Why?
|
Cohort Studies | 1 | 2014 | 41495 | 0.010 |
Why?
|